Evidence map›Paper›PMID 42048026›Full record

ArticleMolecular and cellular biochemistry2026

Nuclear factor I-C as a novel candidate regulator in postoperative atrial fibrillation: integrated omics and proof-of-concept validation.

Chaoyue Gao, Yue Shu, Lin Luo, Ningning Wang, Taiwei Wang, Zexinyao Ren, Pan Shen, Yisi Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chaoyue Gao *Capital Medical University, Beijing, 100069, China.
Yue Shu *Capital Medical University, Beijing, 100069, China.
Lin Luo *Capital Medical University, Beijing, 100069, China.
Ningning WangDepartment of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing, 100850, China.
Taiwei WangCapital Medical University, Beijing, 100069, China.
Zexinyao RenCapital Medical University, Beijing, 100069, China.
Pan ShenDepartment of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing, 100850, China. spluto@foxmail.com.
Yisi LiuCapital Medical University, Beijing, 100069, China. liuyisi@ccmu.edu.cn.

Funding

the General Program of Beijing Natural Science Foundation 7252277the National Natural Science Foundation of China 82200351
6 · The paper itself

Abstract

Postoperative atrial fibrillation (POAF) is a frequent complication of cardiac surgery, yet the upstream transcriptional regulators driving the pro-arrhythmic substrate remain unexplored. We aimed to identify and validate key transcription factors associated with POAF susceptibility. We performed cross-cohort integration of two independent human atrial transcriptomic datasets and applied machine learning (LASSO and SVM-RFE) to prioritize candidate genes. Transcriptional targets were predicted using the TRRUST database and protein-protein interaction (PPI) network analysis. Cellular localization was resolved using murine atrial scRNA-seq data. In vivo functional validation and biochemical signaling assays were performed in a spontaneous POAF (sPOAF) mouse model using AAV9-mediated NFIC overexpression. Nuclear Factor I-C (NFIC) was identified as a robust candidate regulator, showing consistent downregulation in human POAF cohorts and sPOAF mice. By intersecting predicted NFIC targets with the PI3K/Akt pathway, hepatocyte growth factor (HGF) was nominated as a putative downstream effector. Single-cell profiling localized NFIC and HGF predominantly to the atrial fibroblast lineage, where both were significantly downregulated in POAF. In the sPOAF model, p-AKT/AKT ratios were significantly reduced during the acute postoperative phase. Critically, AAV9-mediated NFIC restoration significantly decreased POAF incidence by 50%. Our findings identify NFIC as a novel candidate transcriptional regulator associated with POAF. These data support a working model involving a fibroblast-centered NFIC-HGF-PI3K/AKT axis, providing a fresh framework for understanding the upstream control of the postoperative atrial microenvironment.

Indexed as

Atrial FibrillationPostoperative ComplicationsAnimalsHepatocyte Growth FactorHumansMaleMiceHepatocyte Growth FactorCoronary artery bypass graftingNFICPostoperative atrial fibrillationTranscriptomics

Identifiers

PMID42048026

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.